Fundraising FoxInterwoven Ventures — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Evidium provides predictive analytics and clinical progression modeling for self-insured health plans and employers, forecasting disease evolution and high-cost claim exposure to improve stop-loss underwriting and financial planning.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechInsurTech
Carl Bate(Founder)in
Co-investorsHealth2047IKJ CapitalMindset Venture
Chef Robotics builds AI-powered robots for automated meal assembly and food preparation, designed to handle the natural variability of food ingredients and high-mix production.
AI & Machine LearningFoodTechRobotics
Rajat Bhageria(Founder)in
Co-investorsAlumni VenturesAvataar Venture PartnersBasecamp FundBloomberg BetaBold Capital PartnersConstruct Capital+18 more
Diligent Robotics develops AI-powered robot assistants for healthcare settings, focusing on mobile manipulation and social intelligence to help hospital staff with routine non-patient-facing tasks.
AI & Machine LearningHealthtechMedical DevicesRoboticsAustin, US
Andrea L. Thomaz(Founder)inVivian Chu(Founder)inAndrea Thomaz(Founder)
BoardQuaeed Motiwala(Director)Rohit Sharma(Director)inLance VandenBrook(Director)
Co-investorsATPCanaan PartnersCorrelation VenturesDnx VenturesGaingelsGrit Ventures+12 more
__Twitter.png)
Proscia provides a digital pathology software platform that converts glass microscope slides into high-resolution digital images for viewing, management, and analysis by pathologists and research teams.
AI & Machine LearningBiotechHealthtechMedical DevicesPhiladelphia, US
David West, Jr.(Executive Officer, Director)David West(Founder)inDavid West, Sr.(Executive Officer, Director)Coleman Stavish(Founder)Nathan Buchbinder(Founder)
BoardAlex Niehenke(Director)in
Co-investorsAlpha Intelligence CapitalEmerald Development ManagersFlybridge Capital PartnersFusionGreen Park & Golf VenturesHitachi Ventures+9 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.